Full Length Research Paper
References
|
Aboderi OA, Abdu A, Odetoyin BW, Lamikaura A (2009). Antimicrobial resistance in E. coli strains from urinary tract infections. J. Nat. Med. Assoc. Niger. 01:1268-1273. |
|
|
Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496. |
|
|
Chaturvedi KS, Hung CS, Giblin DE, Urushidani S, Austin AM, Dinauer MC, Henderson JP (2013). Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic. ACS chemical biology. 9(2):551-5861. PubMed: 24283977 |
|
|
Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI (2013). Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci. Translational Med. 5(184):184ra60. |
|
|
Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hoekfelt T, Gudmundsson G, Gallo R, Agerberth B, Brauner (2006). What keeps the urinary tract sterile? The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636-640. |
|
|
Colgan R, Williams M (2011). Diagnosis and Treatment of Acute Uncomplicated Cystitis. American Family Physician 84(7): 771-776. |
|
|
Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB (2013). Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 26:822-880. |
|
|
Daoud Z, Afif C (2011). Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance. Chemotherapy and research Practice. 2011. |
|
|
DeBacker CT, Heytens S, DeSutter A, Stobbering EE, Verschragen G (2008). Evolution of bacterial susceptibility of Esherichia coli inuncomplicated urinary tract infections in a country with high antibiotic consumption: A comparison of two surveys with a ten year interval. J. Antimicrob. Chemother. 62(2):364-368 |
|
|
Duell BL, Carey AJ, Tan CK, et al (2012). Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol. 188:781-792. PubMed: 22184725 |
|
|
Foxman B (2003). Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis. Mon. 49:53-70. PubMed 12601337 |
|
|
Ho YS, Xiong Y, Ma W, Spector A, Ho DS (2004). Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 279(31):32804-12. |
|
|
Kaper JB, Nataro JP, Mobley HL (2004). Pathogenic Escherichia coli. Nature Reviews Microbiol. 2:123-140. |
|
|
Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK (2009). Prevalence of Urinary Tract Infections (UTI) among Patients Attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int. J. Med. Med. Sci. 1(5):163-167. |
|
|
Lane DR, Takhar SS (2011). Diagnosis and Management of Urinary Tract Infection and Pyelonephritis. Emergency Med. Clinics of North Am. 29(3):539-542. |
|
|
Liza DT, Jonathan O (2006). Urinary Tract Infections: Causes, Symptoms and Treatment. Am. J. Epidemiol 132:328-337. |
|
|
Mambula SS, Simons E, Hastey R, Selsted ME, Levitz SM (2000). Human Neutrophil-mediated Nonoxidative Antifungal Activity Against Cryptococcus neoformans. Infec. Immun, 68:6257-6264. |
|
|
Mbata TI (2007). Prevalence and Antibiogram of UTIs among Prisons Inmates in Nigeria. Int. J. Microbiol 3(2):11-15. |
|
|
Morrison G, Kilanowski F, Davidson D, Dorin J (2002,). Characterization of the mouse beta defensing 1, Defbi, mutant mouse model. Infect. Immun. 70:3053-3060. PubMed:12010997 |
|
|
News.sky.com (2016). http://news.sky.com/story/jeremy-hunt-gives-nhs-hospitals-extra-cash-to-fight-superbugs-such-as-ecoli-10647804 |
|
|
Nielsen KL, Dynesen P, Larsen P, Jakobsen L, Andersen PS, Frimodt-Møller N (2014). Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect. Immun. 82(4):1572-1578. PubMed: 24452682 |
|
|
Nicolle LE (2008). Uncomplicated urinary tract infection in adult including uncomplicated Pylonephritis. J. North Am. Urol. 35(1):1-2. |
|
|
Nwachukwu KC, Asagba SO, Nwose C, Okoh MP (2014). Radiation protection and anti-oxidative effects of garlic, onion and ginger extracts, x-ray exposed albino rats as model for biochemical studies. Afri. Jnl. Biochem. Res 8(9):166-173. |
|
|
O'Brien VP, Hannan TJ, Schaefferc AJ, Hultgrena SJ (2015). Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr. Opin Infect. Dis. 28(1):97-105. |
|
|
Paragas N, Kulkarni R, Werth M, et al (2014). Alpha – Intercalated cells defend the urinary system from bacterial infection. J. Clin. Invest. 124: 2963- 2976, PubMed: 24937428 |
|
|
Robinson K, Hotopp D (2016). Bacteria and humans have been swapping DNA for millennia. The Scientist, (http://mobile.the-scientist.com/article/47125/bacteria-and-humans-have-been-swapping-dna-for-millennia) |
|
|
Samuel SO, Salami TAT, Adewuyi GM, Babatope E, Ekozien MI (2012). Prevalence of Urinary Tract Infections among a cohort of HIV Positive Patients accessing care in a rural health centre in Nigeria. J. Microbiol. Biotechnol. Res 2 (4):507-510. |
|
|
Schappert SM, Rechtsteiner EA (2007). Ambulatory medical care utilization estimates for Vital Health Stat 13:1-38. |
|
|
Servin AL (2014). Pathogenesis of Human Diffusely Adhering Escherichia coli Expressing Afa/Dr Adhesins (Afa/Dr DAEC): Current Insights and Future Challenges. Clin. Microbiol. Rev. 27(4):823. |
|
|
Sharef SW, El-Naggari M, Al-Nabhani D, Al Sawai A, Al Muharrmi Z, Elnour I (2015). Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection. J. Infect Public Health 8:458-465. |
|
|
Silva ON, De La Fuente-nú-ez C, Haney EF, Fensterseifer IC, Ribeiro SM, Porto WF, Brown P, Faria-Junior C, Rezende TM, Moreno SE, Lu TK (2016). An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities. Scientific reports. 6. |
|
|
Smith NJ, Varley CL, Eardley I, Feather S, Trejdosiewicz LK, Southgate J (2011). Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. The Journal of urology. 186(3):1084-1092. PubMed 21784459 |
|
|
Taneja N, Rao P, Arora J, and Dogra A (2008). Occurrence of ESBL & Amp – C beta – lactamase & susceptibility to newer antimicrobial agents in complicated UTI. Indian J. Med. Res. 127:85-88. PubMed 18316858 |
|
|
Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF (2012). Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerging infectious diseases. 18(5):741. |
|
|
Thumbikat P, Waltenbaugh C, Schaeffer AJ, Klumpp DJ (2006). Antigen – specific responses accelerate bacterial clearance in the bladder. J. Immunol. 176:3080-3086. PubMed: 16493067 |
|
|
Wright GD (2011). Molecular mechanisms of antibiotic resistance. Chem. Commun. 47:4055-4061. |
|
Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
